CanVirex is a next generation immunotherapeutics company founded as a spin-off from Heidelberg University Hospital and National Center for Tumor Diseases.
CanVirex develops viro-immunotherapeutics for treatment of cancer and platform for vaccination against infectious diseases, specifically COVID-19.

Location

Malzgasse 9, 4052 Basel, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2017

  • Number of employees in Switzerland

    1-9

Key business